neurological diseases, multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, and myasthenia gravis; and RPI-MN for the treatment of the viral diseases, HIV/AIDS, and hepatitis-C. In addition, the company, through its other subsidiary, Designer Diagnostics, Inc., engages in the sale of diagnostic test kits that are used for the identification of infectious human diseases, such as tuberculosis and mycobacterium avium-intracellulare.